{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:29:04Z","timestamp":1792801744036,"version":"4.5.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"vor","delay-in-days":47,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Special Research Fund of the Fourth Affiliated Hospital of Harbin Medical University","award":["HYDSYTB202234"],"award-info":[{"award-number":["HYDSYTB202234"]}],"id":[{"id":"https:\/\/ror.org\/02s7c9e98","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetol Metab Syndr"],"DOI":"10.1186\/s13098-026-02116-0","type":"journal-article","created":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T05:05:57Z","timestamp":1775797557000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Multi-omic profiling reveals Retatrutide alleviates adipose tissue fibrosis via metabolic reprogramming and tissue repair"],"prefix":"10.1186","volume":"18","author":[{"given":"Qingyang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weilun","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzhen","family":"Ran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiqiao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiyu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jindan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xincai","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongfei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,10]]},"reference":[{"key":"2116_CR1","doi-asserted-by":"crossref","unstructured":"Lopez-Yus M et al. Unraveling adipose tissue dysfunction: molecular Mechanisms, novel Biomarkers, and therapeutic targets for liver fat deposition. Cells, 2024. 13(5), 380 .","DOI":"10.3390\/cells13050380"},{"issue":"6","key":"2116_CR2","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1172\/JCI45887","volume":"121","author":"K Sun","year":"2011","unstructured":"Sun K, Kusminski CM, Scherer PE. Adipose tissue remodeling and obesity. J Clin Investig. 2011;121(6):2094\u2013101.","journal-title":"J Clin Investig"},{"issue":"5","key":"2116_CR3","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.molmet.2015.12.001","volume":"5","author":"J Schmitz","year":"2016","unstructured":"Schmitz J, et al. Obesogenic memory can confer long-term increases in adipose tissue but not liver inflammation and insulin resistance after weight loss. Mol Metabolism. 2016;5(5):328\u201339.","journal-title":"Mol Metabolism"},{"issue":"3","key":"2116_CR4","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1111\/obr.12646","volume":"19","author":"F Haczeyni","year":"2018","unstructured":"Haczeyni F, Bell-Anderson KS, Farrell G. Causes and mechanisms of adipocyte enlargement and adipose expansion. Obes Rev. 2018;19(3):406\u201320.","journal-title":"Obes Rev"},{"issue":"3","key":"2116_CR5","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1002\/j.2040-4603.2018.tb00036.x","volume":"8","author":"H Fang","year":"2018","unstructured":"Fang H, Judd RL. Adiponectin regulation and function. Compr Physiol. 2018;8(3):1031\u201363.","journal-title":"Compr Physiol"},{"issue":"12","key":"2116_CR6","doi-asserted-by":"publisher","first-page":"9818","DOI":"10.3390\/ijms24129818","volume":"24","author":"D Szukiewicz","year":"2023","unstructured":"Szukiewicz D. Molecular mechanisms for the vicious cycle between insulin resistance and the inflammatory response in obesity. Int J Mol Sci. 2023;24(12):9818.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"2116_CR7","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.beem.2013.02.005","volume":"27","author":"M Bl\u00fcher","year":"2013","unstructured":"Bl\u00fcher M. Adipose tissue dysfunction contributes to obesity related metabolic diseases. Best Pract Res Clin Endocrinol Metab. 2013;27(2):163\u201377.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"7","key":"2116_CR8","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1111\/obr.12421","volume":"17","author":"A Joao","year":"2016","unstructured":"Joao A, Reis F, Fernandes R. The incretin system ABCs in obesity and diabetes\u2013novel therapeutic strategies for weight loss and beyond. Obes Rev. 2016;17(7):553\u201372.","journal-title":"Obes Rev"},{"issue":"7","key":"2116_CR9","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1016\/j.cmet.2025.04.018","volume":"37","author":"J Teixidor-Deulofeu","year":"2025","unstructured":"Teixidor-Deulofeu J, et al. Semaglutide effects on energy balance are mediated by Adcyap1(+) neurons in the dorsal vagal complex. Cell Metab. 2025;37(7):1530\u2013e15466.","journal-title":"Cell Metab"},{"key":"2116_CR10","doi-asserted-by":"publisher","first-page":"p154843","DOI":"10.1016\/j.metabol.2021.154843","volume":"122","author":"M Rizzo","year":"2021","unstructured":"Rizzo M, Nauck MA, Mantzoros CS. Incretin-based therapies in 2021\u2013Current status and perspectives for the future. Metabolism. 2021;122:p154843.","journal-title":"Metabolism"},{"key":"2116_CR11","doi-asserted-by":"publisher","first-page":"113937","DOI":"10.1016\/j.intimp.2024.113937","volume":"147","author":"W Hu","year":"2025","unstructured":"Hu W, et al. Dual GIP and GLP-1 receptor agonist Tirzepatide alleviates hepatic steatosis and modulates gut microbiota and bile acid metabolism in diabetic mice. Int Immunopharmacol. 2025;147:113937.","journal-title":"Int Immunopharmacol"},{"issue":"7","key":"2116_CR12","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1016\/j.cmet.2024.05.010","volume":"36","author":"A Regmi","year":"2024","unstructured":"Regmi A, et al. Tirzepatide modulates the regulation of adipocyte nutrient metabolism through long-acting activation of the GIP receptor. Cell Metabol. 2024;36(7):1534\u2013e15497.","journal-title":"Cell Metabol"},{"key":"2116_CR13","doi-asserted-by":"publisher","first-page":"868037","DOI":"10.3389\/fendo.2022.868037","volume":"13","author":"E Conceicao-Furber","year":"2022","unstructured":"Conceicao-Furber E, et al. Is glucagon receptor activation the thermogenic solution for treating obesity? Front Endocrinol (Lausanne). 2022;13:868037.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"7","key":"2116_CR14","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1038\/s41591-024-03018-2","volume":"30","author":"AJ Sanyal","year":"2024","unstructured":"Sanyal AJ, et al. Triple hormone receptor agonist Retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial. Nat Med. 2024;30(7):2037\u201348.","journal-title":"Nat Med"},{"issue":"10","key":"2116_CR15","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1038\/s41386-019-0384-x","volume":"44","author":"RM Leon","year":"2019","unstructured":"Leon RM, et al. Hypophagia induced by hindbrain serotonin is mediated through central GLP-1 signaling and involves 5-HT2C and 5-HT3 receptor activation. Neuropsychopharmacology. 2019;44(10):1742\u201351.","journal-title":"Neuropsychopharmacology"},{"issue":"8","key":"2116_CR16","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/S2213-8587(25)00092-0","volume":"13","author":"T Coskun","year":"2025","unstructured":"Coskun T, et al. Effects of Retatrutide on body composition in people with type 2 diabetes: a substudy of a phase 2, double-blind, parallel-group, placebo-controlled, randomised trial. Lancet Diabetes Endocrinol. 2025;13(8):674\u201384.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"5","key":"2116_CR17","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s00228-024-03646-0","volume":"80","author":"M Kaur","year":"2024","unstructured":"Kaur M, Misra S. A review of an investigational drug retatrutide, a novel triple agonist agent for the treatment of obesity. Eur J Clin Pharmacol. 2024;80(5):669\u201376.","journal-title":"Eur J Clin Pharmacol"},{"issue":"7","key":"2116_CR18","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1016\/j.cmet.2024.05.010","volume":"36","author":"A Regmi","year":"2024","unstructured":"Regmi A, et al. Tirzepatide modulates the regulation of adipocyte nutrient metabolism through long-acting activation of the GIP receptor. Cell Metabol. 2024;36(7):1534\u201349. e7.","journal-title":"Cell Metabol"},{"issue":"9","key":"2116_CR19","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1016\/j.cmet.2022.07.013","volume":"34","author":"T Coskun","year":"2022","unstructured":"Coskun T, et al. LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: from discovery to clinical proof of concept. Cell Metab. 2022;34(9):1234\u2013e12479.","journal-title":"Cell Metab"},{"issue":"8","key":"2116_CR20","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/s41587-019-0201-4","volume":"37","author":"D Kim","year":"2019","unstructured":"Kim D, et al. Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype. Nat Biotechnol. 2019;37(8):907\u201315.","journal-title":"Nat Biotechnol"},{"issue":"12","key":"2116_CR21","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated Estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550.","journal-title":"Genome Biol"},{"issue":"5","key":"2116_CR22","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, et al. ClusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16(5):284\u20137.","journal-title":"OMICS"},{"issue":"43","key":"2116_CR23","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci. 2005;102(43):15545\u201350.","journal-title":"Proc Natl Acad Sci"},{"key":"2116_CR24","doi-asserted-by":"crossref","unstructured":"Kagdi S, Lyons SA, Beaudry JL. The interplay of glucose-dependent insulinotropic polypeptide in adipose tissue. J Endocrinol, 2024. 261(3), e230361 .","DOI":"10.1530\/JOE-23-0361"},{"key":"2116_CR25","doi-asserted-by":"crossref","unstructured":"Jones LA, Brierley DI. GLP-1 and the neurobiology of eating control: recent advances. Endocrinology, 2025. 166(2):bqae167 .","DOI":"10.1210\/endocr\/bqae167"},{"issue":"1","key":"2116_CR26","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/s41392-024-01931-z","volume":"9","author":"Z Zheng","year":"2024","unstructured":"Zheng Z, et al. Glucagon-like peptide-1 receptor: mechanisms and advances in therapy. Signal Transduct Target Ther. 2024;9(1):234.","journal-title":"Signal Transduct Target Ther"},{"issue":"3","key":"2116_CR27","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1056\/NEJMoa2206038","volume":"387","author":"AM Jastreboff","year":"2022","unstructured":"Jastreboff AM, et al. Tirzepatide once weekly for the treatment of obesity. N Engl J Med. 2022;387(3):205\u201316.","journal-title":"N Engl J Med"},{"issue":"11","key":"2116_CR28","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1016\/j.cmet.2024.07.023","volume":"36","author":"KF Petersen","year":"2024","unstructured":"Petersen KF, et al. Glucagon promotes increased hepatic mitochondrial oxidation and pyruvate carboxylase flux in humans with fatty liver disease. Cell Metab. 2024;36(11):2359\u201366. e3.","journal-title":"Cell Metab"},{"issue":"1","key":"2116_CR29","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.cld.2013.09.012","volume":"18","author":"C McGown","year":"2014","unstructured":"McGown C, Birerdinc A, Younossi ZM. Adipose tissue as an endocrine organ. Clin Liver Dis. 2014;18(1):41\u201358.","journal-title":"Clin Liver Dis"},{"key":"2116_CR30","doi-asserted-by":"crossref","unstructured":"So J et al. Robust single-nucleus RNA sequencing reveals depot-specific cell population dynamics in adipose tissue remodeling during obesity. Elife, 2025. 13, RP97981 .","DOI":"10.7554\/eLife.97981.3"},{"key":"2116_CR31","doi-asserted-by":"crossref","unstructured":"Mirabelli M et al. Hypoxia in human obesity: new insights from inflammation towards insulin Resistance\u2014A narrative review. Int J Mol Sci, 2024. 25(18), 9802 .","DOI":"10.3390\/ijms25189802"},{"issue":"1","key":"2116_CR32","doi-asserted-by":"publisher","first-page":"10342","DOI":"10.1038\/s41467-024-54080-w","volume":"15","author":"MP Valdecantos","year":"2024","unstructured":"Valdecantos MP, et al. The dual GLP-1\/glucagon receptor agonist G49 mimics bariatric surgery effects by inducing metabolic rewiring and inter-organ crosstalk. Nat Commun. 2024;15(1):10342.","journal-title":"Nat Commun"},{"issue":"8","key":"2116_CR33","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1111\/dom.13212","volume":"20","author":"R Elvert","year":"2018","unstructured":"Elvert R, et al. Running on mixed fuel-dual agonistic approach of GLP-1 and GCG receptors leads to beneficial impact on body weight and blood glucose control: A comparative study between mice and non-human primates. Diabetes Obes Metab. 2018;20(8):1836\u201351.","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"2116_CR34","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.cmet.2024.11.003","volume":"37","author":"X Yu","year":"2025","unstructured":"Yu X, et al. The GIP receptor activates futile calcium cycling in white adipose tissue to increase energy expenditure and drive weight loss in mice. Cell Metab. 2025;37(1):187\u2013e2047.","journal-title":"Cell Metab"},{"issue":"1","key":"2116_CR35","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/s41392-022-01073-0","volume":"7","author":"M Li","year":"2022","unstructured":"Li M, et al. Trends in insulin resistance: insights into mechanisms and therapeutic strategy. Signal Transduct Target Ther. 2022;7(1):216.","journal-title":"Signal Transduct Target Ther"},{"issue":"45","key":"2116_CR36","doi-asserted-by":"publisher","first-page":"eadg4216","DOI":"10.1126\/sciadv.adg4216","volume":"9","author":"N Asahara","year":"2023","unstructured":"Asahara N, et al. A monoclonal antibody activating AdipoR for type 2 diabetes and nonalcoholic steatohepatitis. Sci Adv. 2023;9(45):eadg4216.","journal-title":"Sci Adv"},{"issue":"2","key":"2116_CR37","doi-asserted-by":"publisher","first-page":"197","DOI":"10.2337\/db23-0571","volume":"73","author":"S Zhao","year":"2024","unstructured":"Zhao S, et al. Leptin reduction as a required component for weight loss. Diabetes. 2024;73(2):197\u2013210.","journal-title":"Diabetes"},{"issue":"1","key":"2116_CR38","doi-asserted-by":"publisher","first-page":"2950","DOI":"10.1038\/s41467-022-30646-4","volume":"13","author":"MA Cottam","year":"2022","unstructured":"Cottam MA, et al. Multiomics reveals persistence of obesity-associated immune cell phenotypes in adipose tissue during weight loss and weight regain in mice. Nat Commun. 2022;13(1):2950.","journal-title":"Nat Commun"},{"issue":"11","key":"2116_CR39","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/s41574-023-00887-4","volume":"19","author":"MA van Baak","year":"2023","unstructured":"van Baak MA, Mariman ECM. Obesity-induced and weight-loss-induced physiological factors affecting weight regain. Nat Rev Endocrinol. 2023;19(11):655\u201370.","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"2116_CR40","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/s41418-022-01062-4","volume":"30","author":"X Hildebrandt","year":"2023","unstructured":"Hildebrandt X, Ibrahim M, Peltzer N. Cell death and inflammation during obesity: know my methods, WAT(son). Cell Death Differ. 2023;30(2):279\u201392.","journal-title":"Cell Death Differ"},{"issue":"9","key":"2116_CR41","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1007\/s00125-012-2592-3","volume":"55","author":"YS Lee","year":"2012","unstructured":"Lee YS, et al. Glucagon-like peptide-1 inhibits adipose tissue macrophage infiltration and inflammation in an obese mouse model of diabetes. Diabetologia. 2012;55(9):2456\u201368.","journal-title":"Diabetologia"},{"key":"2116_CR42","doi-asserted-by":"publisher","first-page":"643144","DOI":"10.3389\/fimmu.2021.643144","volume":"12","author":"I Efimova","year":"2021","unstructured":"Efimova I, et al. GIPR signaling in immune cells maintains metabolically beneficial type 2 immune responses in the white fat from obese mice. Front Immunol. 2021;12:643144.","journal-title":"Front Immunol"},{"key":"2116_CR43","doi-asserted-by":"crossref","unstructured":"Shen H et al. The Hippo pathway links adipocyte plasticity to adipose tissue fibrosis. Nat Commun, 2022. 13(1), 6030 .","DOI":"10.1038\/s41467-022-33800-0"},{"issue":"7","key":"2116_CR44","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.2337\/db11-0832","volume":"61","author":"I Elias","year":"2012","unstructured":"Elias I, et al. Adipose tissue overexpression of vascular endothelial growth factor protects against diet-induced obesity and insulin resistance. Diabetes. 2012;61(7):1801\u201313.","journal-title":"Diabetes"},{"issue":"8","key":"2116_CR45","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1038\/s42255-025-01342-6","volume":"7","author":"A de Bray","year":"2025","unstructured":"de Bray A, et al. Fluorescent GLP1R\/GIPR dual agonist probes reveal cell targets in the pancreas and brain. Nat Metab. 2025;7(8):1536\u201349.","journal-title":"Nat Metab"},{"key":"2116_CR46","doi-asserted-by":"publisher","first-page":"101407","DOI":"10.1016\/j.molmet.2021.101407","volume":"55","author":"A Costa","year":"2022","unstructured":"Costa A, et al. Anorectic and aversive effects of GLP-1 receptor agonism are mediated by brainstem cholecystokinin neurons, and modulated by GIP receptor activation. Mol Metab. 2022;55:101407.","journal-title":"Mol Metab"},{"issue":"6","key":"2116_CR47","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1038\/s42255-023-00811-0","volume":"5","author":"K El","year":"2023","unstructured":"El K, et al. The incretin co-agonist Tirzepatide requires GIPR for hormone secretion from human Islets. Nat Metab. 2023;5(6):945\u201354.","journal-title":"Nat Metab"},{"key":"2116_CR48","doi-asserted-by":"publisher","first-page":"102073","DOI":"10.1016\/j.molmet.2024.102073","volume":"91","author":"W Roell","year":"2025","unstructured":"Roell W, et al. Characterization of LY3324954 a long-acting glucagon-receptor agonist. Mol Metab. 2025;91:102073.","journal-title":"Mol Metab"},{"issue":"1","key":"2116_CR49","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s00125-007-0852-4","volume":"51","author":"W Shen","year":"2008","unstructured":"Shen W, et al. R-\u03b1-Lipoic acid and acetyl-L-carnitine complementarily promote mitochondrial biogenesis in murine 3T3-L1 adipocytes. Diabetologia. 2008;51(1):165\u201374.","journal-title":"Diabetologia"},{"issue":"10401","key":"2116_CR50","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/S0140-6736(23)01053-X","volume":"402","author":"J Rosenstock","year":"2023","unstructured":"Rosenstock J, et al. Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA. Lancet. 2023;402(10401):529\u201344.","journal-title":"Lancet"},{"key":"2116_CR51","doi-asserted-by":"publisher","first-page":"116324","DOI":"10.1016\/j.bcp.2024.116324","volume":"225","author":"N Dahdah","year":"2024","unstructured":"Dahdah N, et al. Interrelation of adipose tissue macrophages and fibrosis in obesity. Biochem Pharmacol. 2024;225:116324.","journal-title":"Biochem Pharmacol"}],"container-title":["Diabetology &amp; Metabolic Syndrome"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13098-026-02116-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-026-02116-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-026-02116-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T04:35:17Z","timestamp":1779856517000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13098-026-02116-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,10]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2116"],"URL":"https:\/\/doi.org\/10.1186\/s13098-026-02116-0","relation":{},"ISSN":["1758-5996"],"issn-type":[{"value":"1758-5996","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,10]]},"assertion":[{"value":"2 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal procedures were approved by the Institutional Animal Care and Use Committee (IACUC) of the Fourth Affiliated Hospital of Harbin Medical University (No.:2025-DWSYLLCZ-76).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"120"}}